Jessica Goldenberg

Jessica Goldenberg has over 14 years of work experience in the clinical research industry. Jessica began their career in 2006 as a Clinical Trial Coordinator/Research Department at Belmont Center for Comprehensive Treatment. In 2007, they moved to Neuromed-CombinatoRx (now Zalicus Incorporated) as an In-House CRA. In 2010, they joined PSI CRO AG as a Clinical Trial Specialist. In 2012, they worked at Quintiles as a Clinical Research Associate II, where they monitored Phase II-IV trials throughout the Northeast region in therapeutic areas such as Nephrology, Central Nervous System (Migraine), Dermatology, Rheumatology, and Oncology. In 2014, they joined Inovio Pharmaceuticals Inc. as a Clinical Scientist. In 2015, they moved to IQVIA as a Clinical Lead. In 2017, they joined ACI Clinical as a Project Manager/DMCs. In 2019, they worked at Global Clinical Trials (GCT) as a Project Manager, US Operations. In 2020, they joined Adaptimmune as an Associate Director, Clinical Scientist. Currently, they are working at Autifony Therapeutics as an Associate Director, Clinical Scientist.

Jessica Goldenberg obtained their Bachelor of Arts in Psychology, Neural and Behavioral Sciences from Bryn Mawr College in 2003. Jessica continued their education at Temple University School of Pharmacy, where they earned their Master of Science in RA/QA in 2014.